Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 73Unknown 23Terminated 12Recruiting 8Active not recruiting 4Withdrawn 3Not yet recruiting 2Suspended 1No longer available 1Enrolling by invitation 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 47Breast Neoplasms 47Colorectal Neoplasms 28Prostatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 21Leukemia, Myeloid, Acute 19Glioblastoma 19Pancreatic Neoplasms 17Melanoma 17Lung Neoplasms 17Neoplasm Metastasis 16Glioma 14Stomach Neoplasms 13Ovarian Neoplasms 13Carcinoma, Hepatocellular 13Brain Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Triple Negative Breast Neoplasms 10Myelodysplastic Syndromes 10Multiple Myeloma 10Head and Neck Neoplasms 10Carcinoma, Renal Cell 10Lymphoma 9Uterine Cervical Neoplasms 7Sarcoma 7Rectal Neoplasms 7Leukemia 7Hematologic Neoplasms 7Esophageal Neoplasms 7Colonic Neoplasms 7

Interventions

cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Leukemia, Promyelocytic, Acute × Clear all
NCT04996030 2024-01-23

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

Syros Pharmaceuticals

Phase 1 Suspended
16 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡